|
EPR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.69970004526965E-09 |
| Normal-vs-Stage2 |
6.066100E-02 |
| Normal-vs-Stage3 |
9.38999999977597E-07 |
| Normal-vs-Stage4 |
1.280240E-02 |
| Stage1-vs-Stage2 |
3.768200E-01 |
| Stage1-vs-Stage3 |
1.774660E-04 |
| Stage1-vs-Stage4 |
4.519800E-02 |
| Stage2-vs-Stage3 |
8.735600E-02 |
| Stage2-vs-Stage4 |
1.625020E-01 |
| Stage3-vs-Stage4 |
7.314200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46469511466785E-14 |
| Normal-vs-AfricanAmerican |
1.201840E-04 |
| Normal-vs-Asian |
1.339550E-01 |
| Caucasian-vs-AfricanAmerican |
6.563200E-01 |
| Caucasian-vs-Asian |
6.249800E-01 |
| AfricanAmerican-vs-Asian |
5.240600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1094237467878E-15 |
| Normal-vs-Female |
8.69800000025123E-07 |
| Male-vs-Female |
5.321600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.579000E-04 |
| Normal-vs-Extreme_Weight |
9.27419999685597E-08 |
| Normal-vs-Obese |
8.59000000019705E-08 |
| Normal-vs-Extreme_Obese |
3.078400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.527000E-01 |
| Normal_Weight-vs-Obese |
3.651800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.201500E-02 |
| Extreme_Weight-vs-Obese |
1.366810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.085000E-03 |
| Obese-vs-Extreme_Obese |
3.403000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.817000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.18982642919264E-12 |
| Normal-vs-Age(61-80Yrs) |
1.23860000034171E-07 |
| Normal-vs-Age(81-100Yrs) |
7.620700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.811900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.713500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.038200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.025990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.476000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.885200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.29870020188139E-10 |
| Normal-VS-Type2 PRCC |
9.25240000171357E-08 |
| Normal-VS-KIRP CIMP |
1.682700E-03 |
| Normal-VS-Unclassified PRCC |
1.381890E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.574190E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.180900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.994100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.000410E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.028800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.639000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.434700E-04 |
| Normal-vs-N1 |
1.56561999999916E-05 |
| Normal-vs-N2 |
9.351600E-02 |
| N0-vs-N1 |
1.500410E-03 |
| N0-vs-N2 |
1.939850E-02 |
| N1-vs-N2 |
5.895600E-01 |
|
|
